Medicine and Dentistry
Adverse Event
11%
Age
10%
All Cause Mortality
13%
Analysis
5%
Anticoagulant Therapy
7%
Anticoagulation
23%
Antithrombotic
23%
Antithrombotic Therapy
11%
Artery Thrombosis
11%
Atrial Fibrillation
23%
Cancer Recurrence
11%
Cancer Staging
7%
Cancer Types
13%
Chemotherapy
15%
Cohort Analysis
72%
Death
14%
Development
11%
Direct Oral Anticoagulant
11%
Hazard Ratio
9%
Immune Checkpoint Inhibitor
11%
Inpatient
21%
Life
15%
Lung Cancer
17%
Major Bleeding
7%
Malignant Neoplasm
52%
Microhematuria
11%
Non Small Cell Lung Cancer
6%
Patient
100%
Patient with Cancer
25%
Phlebothrombosis
11%
Pulmonary Embolism
15%
Quality of Life
6%
Recurrence Risk
5%
Secondary Prevention
5%
Therapeutic Procedure
32%
Thromboembolism
15%
Thromboprophylaxis
12%
Treatment Duration
5%
Urinary Tract Cancer
11%
Venous Thromboembolism
76%
Vitamin K Antagonist
13%
Warfarin
6%